SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
EntreMed (ENMD)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
2135 59 0 ENMD
Emcee:  Mark Wise Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2010 Blalvis: Good call last Fri. According to biobiznet.com, ENMD was up +4 for theblackmerlin-1/17/2000
2009 Anyone have any thoughts on the secondary offering for ENMD? Was this expectedGregory Rasp-1/16/2000
2008 I didn't hear "results" (that's your term, not mine), I have zonkerharris-1/15/2000
2007 Where did you hear about "results" in Phase I? They just started and StockDoc-1/13/2000
2006 BLAVIS, How does stock covering (indicating buys) cause a stock price to go dSidney Merle Foster-12/10/1999
2005 The science behind this company is rock solid. I have a substantial investmentzonkerharris-12/10/1999
2004 Well there is a huge short interest in this stock (not a good idea boys)so maybGregory Rasp-12/9/1999
2003 32% move in one day! I was sitting in a doctor's waiting room yesterday andTimeToMakeTheInvs-12/9/1999
2002 <If there are no delays between the rounds than the trial should be at the eGregory Rasp-11/20/1999
2001 Time line for the first Endostatin clinical trial: There can't yet be any Andreas Helke-11/19/1999
2000 Here is the link on the spinoff Gregory - biz.yahoo.com timTimeToMakeTheInvs-11/15/1999
1999 I had seen the earnings report and it is not a total surprise to me that revenuGregory Rasp-11/15/1999
1998 Earnings released on Friday - biz.yahoo.com Supposedly beat estimates by 40 cenTimeToMakeTheInvs-11/14/1999
1997 EntreMed, Inc. to present new positive clincal data for cancer fighting agent aStockReporter-10/31/1999
1996 CHICAGO TRIBUNE ARTICLE By John Crewdson Tribune Staff Writer October 17, 19zonkerharris-10/17/1999
1995 Chicago Tribune article on start of trials chicagotribune.commarc ultra-10/17/1999
1994 New antibody may attack cancer, arthritis - study By Maggie Fox, Health and SciDon Dorsey-10/8/1999
1993 PSA: A Misunderstood Antigen? EntreMed Study in the Journal of the National CanDon Dorsey-10/8/1999
1992 Off topic; Phase 1 news: usnews.comJohn Bloxom-10/1/1999
1991 EntreMed, Inc. Announces Commencement of Patient Enrollment For Phase I ClincalDon Dorsey-9/29/1999
1990 Chicago Tribune Article on Angiogenesis `BREAKTHROUGH' CANCER THEORY IS Qzonkerharris-9/17/1999
1989 NCI responds to WSJ: Text. NCI's Role in the Development of Endostatinzonkerharris-9/15/1999
1988 NCI statement shreds WSJ article to pieces cancertrials.nci.nih.govmarc ultra-9/15/1999
1987 Tommysdad The problem of transportation was in reference to MURINE endostatin,zonkerharris-9/14/1999
1986 Don't you see this as a key phrase? <<Folkman, in an interview, saidtommysdad-9/14/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News